![Andrew Hirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 637 906 $ al 30/06/2026
Andrew J.
Hirsch is President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
Mr. Hirsch is an Independent Director at Editas Medicine, Inc. since 2017.
Formerly, Mr. Hirsch was CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2018 to 2020.
Mr. Hirsch was President, CEO, CAO & Director at DNIB Unwind, Inc. in 2016.
Mr. Hirsch was Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch was VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011.
Mr. Hirsch completed undergraduate studies at the University of Pennsylvania in 1992.
Mr. Hirsch earned an MBA from Tuck School of Business at Dartmouth in 1997.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
C4 THERAPEUTICS, INC. 0,12 % | 22/04/2026 | 135.209 ( 0,12 % ) | 631 426 $ | 30/06/2026 |
| 17/06/2026 | 2.000 ( 0 % ) | 6 480 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDITAS MEDICINE, INC. | Director/Miembro de la Junta | 30/05/2017 |
| C4 THERAPEUTICS, INC. | Director Ejecutivo | 02/10/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director Financiero/CFO | 11/09/2020 |
| DNIB UNWIND INC | Director Ejecutivo | 24/07/2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Director Financiero/CFO | 31/03/2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
